SEED Therapeutics Completes $30 Million Series A-3 Financing GlobeNewswire September 23, 2025 KING OF PRUSSIA, Pa., Sept. 23, 2025 (GLOBE NEWSWIRE) — SEED Therapeutics, Inc. (“SEED”), a clinical-stage biotechnology company pioneering rational molecular glue degraders for historically undruggable disease drivers, today announced the successful completion of its $30 million Series A-3 financing, alongside U.S. Food […]
Presenting on Emerging Growth Conference 86 Day 1 on September 24; Register to live stream GlobeNewswire September 23, 2025 MIAMI, Sept. 23, 2025 (GLOBE NEWSWIRE) — EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 86th Emerging Growth Conference on September 24 & 25, 2025. The Emerging Growth Conference identifies companies
Castle Biosciences Honored with a Greater Pittsburgh Top Workplaces 2025 Award GlobeNewswire September 23, 2025 FRIENDSWOOD, Texas, Sept. 23, 2025 (GLOBE NEWSWIRE) — Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has been recognized as a Greater Pittsburgh Top Workplace by The Pittsburgh
Transpire Bio's ANDA for Generic Breo(R) Ellipta(R) Accepted for Filing By the U.S. FDA GlobeNewswire September 23, 2025 SUNRISE, Fla., Sept. 23, 2025 (GLOBE NEWSWIRE) — Transpire Bio, an integrated clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, today announces that its abbreviated new drug application (ANDA) for fluticasone furoate
Supply Chain Digital Releases 100 Companies Shaping Supply Chains 2025 GlobeNewswire September 23, 2025 London, UK – 23 September 2025 – Supply Chain Digital, a leading BizClik brand, has released its highly anticipated report which celebratings the 100 companies shaping supply chains for 2025. This annual ranking recognises the organisations that are setting new benchmarks
Amphista Therapeutics discloses first details of its TEAD Targeted Glue(TM) program and unveils new mechanism of action for TEAD degradation via FBXO22 GlobeNewswire September 23, 2025 Amphista Therapeutics discloses first details of its TEAD Targeted Glue(TM) program and unveils new mechanism of action for TEAD degradation via FBXO22 First disclosure of a novel mechanism of
Calian Launches Canada's First Defence Innovation Orchestrator to Scale Small to Mid-Sized Enterprise Calian Ventures designed to test, validate and scale innovative SME ideas for the Canadian Armed Forces GlobeNewswire September 23, 2025 OTTAWA, Ontario, Sept. 23, 2025 (GLOBE NEWSWIRE) — Calian Group Ltd. (TSX: CGY), a trusted provider of mission-critical solutions for defence, space,
Microbix Assisting EMQN with Second Genetic-Test EQA Program Helping Ensure Appropriate Dosing of Widely-Used Anti-Clotting Drugs GlobeNewswire September 23, 2025 MISSISSAUGA, Ontario and MANCHESTER, United Kingdom, Sept. 23, 2025 (GLOBE NEWSWIRE) — Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix(R)), a life sciences innovator, manufacturer, and exporter, and EMQN CIC (EMQN), a global supplier of laboratory external
(NYSE:AZO), MEMPHIS, Tenn., Sept. 23, 2025 (GLOBE NEWSWIRE) — AutoZone, Inc. (NYSE: AZO) today reported net sales of $6.2 billion for its fourth quarter (16 weeks) ended August 30, 2025, an increase of 0.6% from the fourth quarter of fiscal 2024 (17 weeks). Excluding sales from the additional week included in last year's quarter, adjusted
The report “Data Center Coolant Distribution Units Marketby Type (In-Row, In-Rack, FDU), Cooling Type (Direct to Chip Cooling, Immersion Cooling), End User (Colocation Providers, Enterprises, Hyperscale), and Region Global Forecast to 2032”, data center coolant distribution units market is projected to grow from USD 1.05 billion in 2025 to USD 7.74 billion by 2032, at